关于阿姆洛迪平诱导的牙扩张的新见解:临床和分子视角
Jana Mojsilović1, Nemanja Jovičić2, Sanja Vujović Ristić1
1Department of Dentistry, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Pharmaceuticals (Basel, Switzerland)
|August 29, 2024
概括
阿姆洛迪平诱导的牙扩大会影响口腔健康和生活质量,与纤维化和氧化应激有关. 识别这些因素对于更好的患者护理和进一步的研究至关重要.
科学领域:
- 口腔医学是指口腔医学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 阿姆洛迪平是一种常见的抗高血压药,可以导致牙扩大,影响患者的福祉.
- 了解潜在的机制和患者影响对于有效的管理至关重要.
研究的目的:
- 为了确定阿姆洛狄平诱导的牙扩张的危险因素.
- 评估对患者生活质量的影响.
- 分析牙组织的分子和氧化应激标志物.
主要方法:
- 在阿姆洛迪平治疗高血压患者的横截面研究,有或没有牙扩大.
- 临床评估,社会人口统计数据收集和生活质量调查问卷 (OHIP-14,WB-HRQoL).
- 使用RT-PCR进行基因表达和氧化状态色度测试 (SOD,MDA) 的牙组织分析.
主要成果:
- 患有牙扩张的患者表现出较高的缩血压和较差的生活质量 (OHIP-14评分).
- 在IL-6,TNF-α,IL-33,ST2,TGF-β1,FGF-2,CTGF,VEGF-D和KGF的基因表达中观察到显著的差异.
- 在阿姆洛迪平诱导的牙扩大时,注意到TGF-β1和CTGF表达的增加,以及较高的SOD活性,这表明纤维化和氧化应激.
结论:
- 阿姆洛迪平诱导的牙扩大与特定的分子变化 (TGF-β1,CTGF) 和氧化应激标志物有关.
- 这种情况会对口腔健康相关的生活质量产生负面影响.
- 建议采用综合医疗保健方法和进一步研究来管理这种副作用.
相关概念视频
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
464
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
464
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
614
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
614
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
473
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
473
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
147
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
147